Current status and research progress in drug therapy for castration-resistant prostate cancer / 中国肿瘤临床

ABSTRACT

The incidence and mortality of prostate cancer have steadily increased. As such, the prevention and treatment of prostate cancer are important. Standardized drug therapy in patients with castration-resistant prostate cancer (CRPC) is crucial for improving survival and quality of life. Here, we review the current situation and latest research progress in drug therapy for CRPC.